Summary

Persistence Market Research offers a comprehensive analysis of the Opioids Market, providing valuable insights into its complex dynamics and future outlook. This report covers market trends, growth drivers, challenges, and emerging patterns, with detailed statistics and forecasts from 2024 to 2033.

Key Insights:

• Market Size in 2024: USD 45.75 Billion
• Projected Market Value in 2033: USD 61.1 Billion
• Global Growth Rate (CAGR 2024-2033): 3.3%

Report Scope:

The Opioids Market spans various applications within the healthcare, pharmaceuticals, and pain management sectors. Opioids are essential for treating moderate to severe pain, including post-surgical, cancer-related, and chronic pain. Key end-users include hospitals, clinics, and home care settings, making opioids vital for pain management solutions. Market growth is driven by the increasing prevalence of chronic pain, advancements in drug formulations, and the rising need for effective pain management therapies.

Market Growth Drivers:

Several factors propel the growth of the global Opioids Market. The rising incidence of chronic pain conditions and an aging population increase the demand for effective pain management. Advancements in drug formulations improve the efficacy and safety of opioids, encouraging their use in various medical settings. Additionally, the growing number of surgical procedures and cancer treatments drives the need for opioids as essential pain relievers.

Market Restraints:

Despite promising growth, the Opioids Market faces challenges such as regulatory compliance, addiction concerns, and competition from alternative pain management therapies. Strict regulatory requirements on opioid prescribing and usage impose burdens on healthcare providers and manufacturers, affecting market growth. The risk of addiction and misuse presents significant public health challenges, necessitating stringent controls and patient monitoring. Furthermore, the competition from non-opioid analgesics and alternative pain management approaches can hinder market expansion.

Market Opportunities:

The Opioids Market offers significant growth opportunities driven by technological innovations, industry collaborations, and market diversification. Trends such as abuse-deterrent formulations, personalized medicine, and telemedicine encourage manufacturers to explore new opioid formulations and delivery methods. Strategic partnerships, research collaborations, and mergers and acquisitions enable companies to expand their product portfolios, enhance technical capabilities, and strengthen their presence in key regions. Increased investments in research and development, along with government support for innovation and public health initiatives, create a favorable environment for market growth and diversification.

Key Questions Answered in the Report:

• What are the primary factors driving the global Opioids Market growth?
• How are technological advancements and industry trends influencing opioid formulations and delivery methods?
• What are the key challenges and opportunities for market participants in the opioids segment?
• Which medical sectors and geographic regions offer the highest growth potential for opioid manufacturers?
• What strategies are leading companies using to differentiate their opioid products and capture market share?

Competitive Intelligence and Business Strategy:

Leading players in the global Opioids Market, including pharmaceutical companies and healthcare providers, focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to create advanced drug formulations, improve product safety, and explore new opioid applications for pain management. Strategic collaborations with research institutions, academic partners, and healthcare associations allow market players to access new technologies, expand their knowledge base, and accelerate product development. Emphasizing regulatory compliance, quality assurance, and patient support enhances brand reputation and fosters long-term relationships with customers and stakeholders.

Key Companies Profiled:

• Johnson & Johnson Services, Inc.
• Purdue Pharma L.P.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Mallinckrodt Pharmaceuticals
• Endo International plc
• AbbVie Inc.
• Sun Pharmaceutical Industries Ltd.
• Mylan N.V.
• Boehringer Ingelheim International GmbH
• Egalet Corporation
• Orexo AB

Market Research Segmentation:

By Product:

• Morphine
• Codiene
• Fentanyl
• Meperidine
• Methadone

By Application:

• Analgesia
• Cough Suppression
• Diarrhea Suppression

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Store
• Clinics
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Adoption Rate/Usage Analysis – Key Statistics
4.2. Value Chain Analysis
4.3. Key Regulations – By Region
4.4. Product USP Analysis
4.5. Pipeline Assessment
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Analgesics Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Prevalence of Chronic Diseases and Trauma Conditions
5.2.2. Less Availability of Opioids in African Nations
5.2.3. Increasing Product Approvals
5.2.4. Increasing Commercialization of Products
5.2.5. Mergers and Acquisitions
5.2.6. Regulatory Policies
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Application
6.1.3. By Distribution Channel
6.1.4. By Region
6.2. 2024 Market Scenario
7. Global Opioids Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Opioids Market Analysis 2019-2023 and Forecast 2024-2033, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
8.3.1. Morphine
8.3.2. Codiene
8.3.3. Fentanyl
8.3.4. Meperidine
8.3.5. Methadone
8.4. Market Attractiveness Analysis, by Product
9. Global Opioids Market Analysis 2019-2023 and Forecast 2024-2033, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Application, 2024-2033
9.3.1. Analgesia
9.3.2. Cough Suppression
9.3.3. Diarrhea Suppression
9.4. Market Attractiveness Analysis, by Application
10. Global Opioids Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Distribution Channel, 2024-2033
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Drug Store
10.3.4. Clinics
10.3.5. Others
10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Opioids Market Analysis 2019-2023 and Forecast 2024-2033, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
11.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, By Region, 2024-2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis, by Region
12. North America Opioids Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Application
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Application
12.4.4. By Distribution Channel
12.5. Market Trends
12.6. Key Market Participants – Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. U.S. Opioids Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast, by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By Application
12.8.1.2.3. By Distribution Channel
12.8.2. Canada Opioids Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast, by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By Application
12.8.2.2.3. By Distribution Channel
13. Latin America Opioids Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Application
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Application
13.4.4. By Distribution Channel
13.5. Market Trends
13.6. Key Market Participants – Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Mexico Opioids Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast, by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Application
13.8.1.2.3. By Distribution Channel
13.8.2. Brazil Opioids Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast, by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Application
13.8.2.2.3. By Distribution Channel
13.8.3. Argentina Opioids Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast, by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By Application
13.8.3.2.3. By Distribution Channel
14. Europe Opioids Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Application
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By Distribution Channel
14.5. Market Trends
14.6. Key Market Participants – Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Opioids Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application
14.8.1.2.3. By Distribution Channel
14.8.2. Italy Opioids Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Application
14.8.2.2.3. By Distribution Channel
14.8.3. France Opioids Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast, by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Application
14.8.3.2.3. By Distribution Channel
14.8.4. U.K. Opioids Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast, by Market Taxonomy
14.8.4.2.1. By Product
14.8.4.2.2. By Application
14.8.4.2.3. By Distribution Channel
14.8.5. Spain Opioids Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast, by Market Taxonomy
14.8.5.2.1. By Product
14.8.5.2.2. By Application
14.8.5.2.3. By Distribution Channel
14.8.6. BENELUX Opioids Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast, by Market Taxonomy
14.8.6.2.1. By Product
14.8.6.2.2. By Application
14.8.6.2.3. By Distribution Channel
14.8.7. Russia Opioids Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast, by Market Taxonomy
14.8.7.2.1. By Product
14.8.7.2.2. By Application
14.8.7.2.3. By Distribution Channel
15. East Asia Opioids Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Distribution Channel (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By Application
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Application
15.4.3. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. China Opioids Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By Distribution Channel
15.8.2. Japan Opioids Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.2.2.3. By Distribution Channel
15.8.3. South Korea Opioids Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application
15.8.3.2.3. By Distribution Channel
16. South Asia Opioids Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Application
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Opioids Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By Distribution Channel
16.8.2. Indonesia Opioids Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. By Distribution Channel
16.8.3. Malaysia Opioids Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application
16.8.3.2.3. By Distribution Channel
16.8.4. Thailand Opioids Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Application
16.8.4.2.3. By Distribution Channel
17. Oceania Opioids Market 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Application
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By Distribution Channel
17.5. Key Market Participants - Intensity Mapping
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. Australia Opioids Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.1.2.3. By Distribution Channel
17.8.2. New Zealand Opioids Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.2.2.3. By Distribution Channel
18. Middle East and Africa (MEA) Opioids Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Application
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.4.2. By Application
18.4.3. By Distribution Channel
18.5. Market Trends
18.6. Key Market Participants – Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Opioids Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application
18.8.1.2.3. By Distribution Channel
18.8.2. Turkey Opioids Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application
18.8.2.2.3. By Distribution Channel
18.8.3. South Africa Opioids Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Application
18.8.3.2.3. By Distribution Channel
18.8.4. North Africa Opioids Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Application
18.8.4.2.3. By Distribution Channel
19. Market Structure Analysis
19.1. Market Analysis, by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Pfizer, Inc.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Key Financials
20.3.1.5. SWOT Analysis
20.3.1.6. Strategy Overview
20.3.1.6.1. Marketing Strategy
20.3.1.6.2. Product Strategy
20.3.1.6.3. Channel Strategy
20.3.2. Boehringer Ingelheim International GmbH
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Key Financials
20.3.2.5. SWOT Analysis
20.3.2.6. Strategy Overview
20.3.2.6.1. Marketing Strategy
20.3.2.6.2. Product Strategy
20.3.2.6.3. Channel Strategy
20.3.3. Janssen Pharmaceuticals, Inc.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Key Financials
20.3.3.5. SWOT Analysis
20.3.3.6. Strategy Overview
20.3.3.6.1. Marketing Strategy
20.3.3.6.2. Product Strategy
20.3.3.6.3. Channel Strategy
20.3.4. Sanofi SAIS
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Key Financials
20.3.4.5. SWOT Analysis
20.3.4.6. Strategy Overview
20.3.4.6.1. Marketing Strategy
20.3.4.6.2. Product Strategy
20.3.4.6.3. Channel Strategy
20.3.5. Sun Pharmaceutical Industries Ltd.
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Key Financials
20.3.5.5. SWOT Analysis
20.3.5.6. Strategy Overview
20.3.5.6.1. Marketing Strategy
20.3.5.6.2. Product Strategy
20.3.5.6.3. Channel Strategy
20.3.6. Actavis Plc. [Teva Pharmaceutical Industries Ltd.]
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Key Financials
20.3.6.5. SWOT Analysis
20.3.6.6. Strategy Overview
20.3.6.6.1. Marketing Strategy
20.3.6.6.2. Product Strategy
20.3.6.6.3. Channel Strategy
20.3.7. Mallinckrodt Pharmaceuticals
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Key Financials
20.3.7.5. SWOT Analysis
20.3.7.6. Strategy Overview
20.3.7.6.1. Marketing Strategy
20.3.7.6.2. Product Strategy
20.3.7.6.3. Channel Strategy
20.3.8. Endo Pharmaceuticals Inc. [Endo International plc]
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Key Financials
20.3.8.5. SWOT Analysis
20.3.8.6. Strategy Overview
20.3.8.6.1. Marketing Strategy
20.3.8.6.2. Product Strategy
20.3.8.6.3. Channel Strategy
20.3.9. Purdue Pharma L.P.
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Key Financials
20.3.9.5. SWOT Analysis
20.3.9.6. Strategy Overview
20.3.9.6.1. Marketing Strategy
20.3.9.6.2. Product Strategy
20.3.9.6.3. Channel Strategy
20.3.10. Assertio Therapeutics, Inc. (Assertio Holdings, Inc.)
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Key Financials
20.3.10.5. SWOT Analysis
20.3.10.6. Strategy Overview
20.3.10.6.1. Marketing Strategy
20.3.10.6.2. Product Strategy
20.3.10.6.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology